Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

China flag China · Delayed Price · Currency is CNY
90.00
-0.90 (-0.99%)
Mar 3, 2026, 3:00 PM CST
14.85%
Market Cap 40.50B
Revenue (ttm) 5.17B
Net Income (ttm) 2.18B
Shares Out 450.00M
EPS (ttm) 4.85
PE Ratio 18.56
Forward PE 17.62
Dividend 0.80 (0.88%)
Ex-Dividend Date Sep 10, 2025
Volume 4,252,034
Average Volume 3,447,567
Open 90.58
Previous Close 90.90
Day's Range 89.59 - 92.17
52-Week Range 72.38 - 122.20
Beta 0.39
RSI 28.76
Earnings Date Apr 23, 2026

About SHA:688578

Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China. Its lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC), as well as for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 1,823
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688578
Full Company Profile

Financial Performance

In 2025, SHA:688578's revenue was 5.17 billion, an increase of 45.36% compared to the previous year's 3.56 billion. Earnings were 2.18 billion, an increase of 52.55%.

Financial Statements

News

There is no news available yet.